BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2873903)

  • 1. Inhibition of steroid-inducible tyrosine aminotransferase gene expression by N-methyl-N'-nitro-N-nitrosoguanidine in a rat hepatoma cell line.
    Miller MS; Wogan GN
    Carcinogenesis; 1986 Aug; 7(8):1273-8. PubMed ID: 2873903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of N-methyl-N'-nitro-N-nitrosoguanidine on constitutive and hormone-inducible gene expression in rat hepatoma cells.
    Miller MS
    Chem Biol Interact; 1990; 73(2-3):207-19. PubMed ID: 1690087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-N'-nitro-N-nitrosoguanidine and benzo[a]pyrene-7,8-diol-9,10-epoxide inhibit glucocorticoid-inducible polyoma virus middle-T gene expression in rat mT-1 cells by a post-transcriptional mechanism.
    Miller MS; Kono M; Wogan GN
    Carcinogenesis; 1987 Aug; 8(8):1159-63. PubMed ID: 3038361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement by streptozotocin and N-methyl-N'-nitro-N-nitrosoguanidine of the tyrosine aminotransferase activity in cultured rat liver cells: role of dexamethasone and NAD.
    Hoshino J; Studinger G; Kröger H
    Chem Biol Interact; 1980 Nov; 32(3):267-79. PubMed ID: 6159116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for translational regulation of tyrosine aminotransferase synthesis by dibutyryl cyclic AMP in Reuber H35 hepatoma cells.
    Snoek GT; Voorma HO; Van Wijk R
    Biochim Biophys Acta; 1981 Aug; 655(1):107-12. PubMed ID: 6114749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse correlation between dexamethasone 21-mesylate agonist activity and sensitivity to dexamethasone for induction of tyrosine aminotransferase in rat hepatoma cells.
    Simons SS; Miller PA; Wasner G; Miller NR; Mercier L
    J Steroid Biochem; 1988 Jul; 31(1):1-7. PubMed ID: 2899655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of tyrosine aminotransferase by glucocorticoids and insulin.
    Gadson P; McCoy J
    Biochim Biophys Acta; 1993 Apr; 1173(1):22-31. PubMed ID: 8097930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-mediated regulation of tyrosine aminotransferase in rat hepatoma cells: inhibition of transcription and inhibition of enzyme degradation.
    Moore PS; Koontz JW
    Arch Biochem Biophys; 1989 Dec; 275(2):486-95. PubMed ID: 2574563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional and posttranscriptional regulation of tyrosine aminotransferase by insulin in rat hepatoma cells.
    Crettaz M; Muller-Wieland D; Kahn CR
    Biochemistry; 1988 Jan; 27(1):495-500. PubMed ID: 2894848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in some molecular events during the early phases of the Reuber H35 cell cycle. IV-regulation of tyrosine aminotransferase.
    van Wijk R; Loesberg L; Snoek GT
    Biochimie; 1983; 65(11-12):643-52. PubMed ID: 6143573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sensitivity of HTC and Fu5-5 cells for induction of tyrosine aminotransferase by 3',5'-cyclic adenosine monophosphate.
    Wasner G; Simons SS
    Mol Endocrinol; 1987 Jan; 1(1):109-20. PubMed ID: 2901031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A post-transcriptional site of induction of tyrosine aminotransferase by dexamethasone in Reuber H35 hepatoma cells.
    Snoek GT; Voorma HO; van Wijk R
    FEBS Lett; 1981 Mar; 125(2):266-70. PubMed ID: 6112172
    [No Abstract]   [Full Text] [Related]  

  • 13. Positive and negative cAMP-mediated control of tyrosine aminotransferase synthesis in Reuber H35 hepatoma cells.
    Snoek GT; Voorma HO; van Wijk R
    Eur J Biochem; 1982 Mar; 123(1):217-22. PubMed ID: 6121706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tyrosine aminotransferase gene expression by retinoic acid.
    Pan CJ; Shelly LL; Rabin DS; Chou JY
    Mol Endocrinol; 1992 Apr; 6(4):572-80. PubMed ID: 1350056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of glucocorticoid induction of stably transfected tyrosine aminotransferase gene constructs involves elements up-stream of the glucocorticoid-responsive element.
    Szapary D; Oshima H; Simons SS
    Endocrinology; 1992 Jun; 130(6):3492-502. PubMed ID: 1350762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of metabolic inhibitors on the synthesis of inducible tyrosine aminotransferase in cultured hepatoma cells.
    Dethlefsen LA
    J Cell Physiol; 1975 Aug; 86(1):155-65. PubMed ID: 240862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation of the transcription of the tyrosine aminotransferase gene by glucocorticoids in Morris hepatoma 7777 and 8994 cells].
    Adler VV; Krasil'nikov MA; Polotskaia AV
    Mol Biol (Mosk); 1988; 22(2):423-9. PubMed ID: 2899290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by sodium butyrate of enzyme induction by glucocorticoids and dibutyryl cyclic AMP. A role for the rapid form of histone acetylation.
    Plesko MM; Hargrove JL; Granner DK; Chalkley R
    J Biol Chem; 1983 Nov; 258(22):13738-44. PubMed ID: 6196355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute effect of lead acetate on glucocorticoid regulation of tyrosine aminotransferase in hepatoma cells.
    Heiman AS; Tonner LE
    Toxicology; 1995 Jun; 100(1-3):57-68. PubMed ID: 7624883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of glucocorticoid induction of tyrosine aminotransferase gene expression by variations in cell density.
    Oshima H; Simons SS
    Endocrinology; 1992 Apr; 130(4):2106-12. PubMed ID: 1347740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.